Targeted Molecular Construct for Bioorthogonal Theranostics of PD-L1-Expressing Cancer Cells. (2022)
Attributed to:
Palladium-activated prodrug therapy: a novel focal therapy for localised cancers of unmet need
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/jacsau.2c00328
PubMed Identifier: 35911461
Publication URI: http://europepmc.org/abstract/MED/35911461
Type: Journal Article/Review
Volume: 2
Parent Publication: JACS Au
Issue: 7
ISSN: 2691-3704